Changeflow GovPing Healthcare & Life Sciences ADEPT Diarrhea Prediction Tool Pilot, LMICs
Routine Notice Added Final

ADEPT Diarrhea Prediction Tool Pilot, LMICs

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NIH has registered a pilot before-after feasibility trial testing the Accessible Diarrhea Etiology Prediction Tool (ADEPT), a mobile phone-based clinical decision-support application, among informally trained healthcare providers in low- and middle-income countries. The study aims to assess the tool's acceptability, feasibility, and utility in reducing inappropriate antibiotic prescribing for pediatric diarrhea. Participants will use the ADEPT application during routine patient care, with outcomes measured before and after implementation.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a clinical trial (NCT07538531) evaluating the ADEPT mobile application as a clinical decision-support tool for informal healthcare providers treating pediatric diarrhea in low- and middle-income countries. The pilot before-after feasibility trial will measure changes in antibiotic prescribing behavior following introduction of the tool, assessing acceptability, feasibility, and utility. The study targets informal healthcare providers who commonly serve as the first point of care for children under 5 in these settings and prescribe antibiotics at high rates despite rehydration being the accepted best practice for non-severe, non-cholera diarrhea.

Healthcare providers and researchers focused on pediatric care in LMICs should be aware that this study will generate evidence on whether mobile-based decision-support tools can meaningfully reduce inappropriate antibiotic prescribing in informal care settings. The results may inform future public health interventions targeting antimicrobial resistance in resource-limited environments.

Archived snapshot

Apr 20, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Utility and Feasibility of Accessible Diarrhea Etiology Prediction Tool (ADEPT) in an Informal Healthcare Setting

N/A NCT07538531 Kind: NA Apr 20, 2026

Abstract

Diarrheal disease remains a leading cause of morbidity and mortality for children under 5 globally. Accepted best practice for managing diarrhea in the absence of blood or suspicion of cholera is rehydration, however in resource poor areas antibiotics are still prescribed at high rates due to pressures such as financial incentives, caregiver expectations, and diagnostic uncertainty. Informal healthcare providers often serve as first point of care for pediatric diarrhea patients in low- and middle- income countries (LMICs) and commonly prescribe antibiotics for pediatric diarrhea at high frequencies.

In this pilot before-after feasibility trial informally trained healthcare providers will use a mobile phone-based application (Accessible Diarrhea Etiology Prediction Tool, ADEPT) which will allow for the exploration of the acceptability, feasibility, and utility of the tool, as well as ADEPTs ability to decrease inappropriate antibiotic prescribing practices.

Conditions: Diarrhea Infectious, Algorithms, Decision Support Systems, Clinical, Clinical Decision-making

Interventions: Diagnostic test: Accessible Diarrhea Etiology Prediction Tool (ADEPT)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07538531

Who this affects

Applies to
Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial Feasibility study Antibiotic stewardship
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!